UZE

United States Cellular Corporat (UZE) 10Y Growth Potential Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-08-01

Revenue Growth Drivers

Negative 5-year revenue CAGR data limits evidence of durable top-line compounding, leaving UZE below stronger peer growers with documented multi-year expansion.

ROIC of 11.7% suggests reinvested capital can still generate acceptable returns, but peers with higher proven returns typically support faster compounding.

Interest coverage of 10.5x preserves financing flexibility for selective growth investment, yet leverage alone does not create revenue expansion versus faster-scaling peers.

The absence of reported 5-year EPS and FCF CAGR reduces visibility into repeatable growth conversion, weakening confidence relative to peers with fuller track records.

Market Tailwinds

No direct evidence of structural demand acceleration is provided, so UZE appears more dependent on execution than peers with clearer multi-year tailwinds.

A negative cash conversion cycle of -88.6 days can support working-capital efficiency, but it does not by itself indicate stronger market-led revenue growth.

Capex intensity of 46.9% of revenue implies ongoing asset replacement or expansion needs, which can support growth but also signals heavier reinvestment than lighter-capex peers.

Without segment concentration data, the company’s exposure to faster-growing end markets cannot be validated, leaving its tailwind profile weaker than better-disclosed peers.

Scalability Expansion

Net debt to EBITDA of 0.88x leaves moderate balance-sheet capacity for expansion, but peers with stronger cash generation can usually scale more aggressively.

Capex to operating cash flow of -33.6% indicates investment is being funded, yet the scale of reinvestment appears less clearly compounding than top-tier peers.

ROIC above 10% supports some reinvestment scalability, but the lack of proven multi-year growth metrics prevents assigning a stronger compounding profile.

The business appears capable of incremental expansion, but structural evidence for rapid, repeatable scaling remains weaker than for high-growth peer platforms.

Constraints Limitations

High capex intensity constrains free cash flow flexibility, which can limit the pace of self-funded expansion versus more asset-light peers.

Negative free cash flow yield suggests current capital deployment is not yet translating into visible shareholder cash generation, reducing compounding visibility.

Missing long-term growth history and segment data create an evidence gap, making it harder to confirm durable scalability relative to peers.

Leverage is manageable, but capital intensity and limited disclosed growth track record together cap the company’s long-term growth score.

Overall Score

UZE shows moderate long-term growth capacity: acceptable reinvestment returns and manageable leverage support expansion, but limited disclosed growth history and high capital intensity cap scalability versus stronger peers.

Score Driver: Capital Intensity

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on United States Cellular Corporat. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →